Merck KGaA at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
Merck KGaA brings 7 presentations to PEGS Europe 2026 in Lisbon. Its program centres on digital and computational tools for antibody and ADC discovery, from AI-guided single domain antibody selection to in silico antibody design. It also covers predicting the light stability of ADC payloads, and antibody-derived receptor agonists for targeted immunomodulation.
| Organization | PEGS Europe 2026 Attendance |
|---|---|
Merck KGaA Darmstadt, Germany | |
German science and technology group whose healthcare business develops antibodies, ADCs and other biologics; it also runs a life science tools business. | Talk Tue Nov 17 3:05pm–3:35pm Talk Tue Nov 17 4:50pm–5:20pm Panel Tue Nov 17 5:50pm–6:20pm Chair Thu Nov 19 8:25am–8:30am Chair Thu Nov 19 10:44am–10:45am Talk Thu Nov 19 10:45am–11:15am Talk Thu Nov 19 4:45pm–5:15pm |
Instantly find 20 buyers from Merck KGaA
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction